Position in HLN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$66,942,750
-$96,586,500 QoQ
Shares Held
7,175,000
-55.6% QoQ
Ownership
0.163%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#13
of 639 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. HLN ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
This page
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in HLN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,942,750 | 7,175,000 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $163,529,250 | 16,175,000 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $2,851,750 | 275,000 | Shares | Sole | 2025-08-13 | |
| No filing history on record for this holder in this stock. | ||||||